• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Formos Med Assoc . Serological response to avian influenza viruses among occupationally exposed population in Taiwan, a longitudinal cohort study

tetano

Editor, Senior Moderator
J Formos Med Assoc


. 2024 Dec 16:S0929-6646(24)00576-X.
doi: 10.1016/j.jfma.2024.12.017. Online ahead of print. Serological response to avian influenza viruses among occupationally exposed population in Taiwan, a longitudinal cohort study, 2021-2023

Tsung-Pei Tsou[SUP] 1 [/SUP], Chieh-Yu Lin[SUP] 1 [/SUP], Shu-Er Yang[SUP] 1 [/SUP], Hui-Tzu Wang[SUP] 1 [/SUP], I-Ling Yu[SUP] 1 [/SUP], Ming-Tsan Liu[SUP] 1 [/SUP], Yi-Chien Chih[SUP] 1 [/SUP]



Affiliations
Abstract

The Taiwan Centers for Disease Control (TCDC) initiated longitudinal sero-epidemiological surveillance of avian influenza viruses (AIVs) targeting poultry workers exposed on affected farms since 2021. Convalescent-phase serum samples were collected from these workers 21-28 days post-outbreak identification. TCDC recontacted participants in subsequent years for repeat serological sampling. Hemagglutination inhibition (HI) assays were used to test against representative strains of AIV A/H5 2.3.4.4c and A/H5 2.3.4.4b. By the end of 2023, a 2-year cohort of 59 participants and a 3-year cohort of 61 participants were established. None of them had laboratory-confirmed infection. HI titers against AIV A/H5 2.3.4.4c remained low from 2021 to 2023. For AIV A/H5 2.3.4.4b, HI titer remained low from 2021 to 2022 but increased in more than half of the participants (60%, 72/120) in 2023. This change parallels the increasing AIV A/H5 2.3.4.4b burden indicated by increased outbreaks and warrants continuous monitoring.

Keywords: Avian; Human; Influenza; Influenza A virus; Seroprevalence.

 
Back
Top Bottom